AnaptysBio logo

AnaptysBio

AnaptysBio is a biotechnology company developing antibody products for the treatment of inflammation and severe diseases.

3

Funding Rounds

$75.0m

Money raised

Overview

AnaptysBio is a biotechnology company developing antibody products for the treatment of inflammation and severe diseases.

Funding

Funding series

Funding Series Analysis

The company AnaptysBio has raised a total of $75m in funding over 3 rounds.

Key Insights:

  • AnaptysBio Series D round Funding Round 2015: $40m
  • AnaptysBio Series B round: $33m
  • AnaptysBio Series A round: $2m
AnaptysBio logo
AnaptysBio Series D round Funding Round 2015 $40m
AnaptysBio logo
AnaptysBio Series B round $33m
AnaptysBio logo
AnaptysBio Series A round $2m

Industries

AnaptysBio is active in the following industries: